Drug-induced autoimmune disorders

Drug Information Journal

Volumn 30, Issue 1, 1996, Pages 293-299

  Kammüller, Michael E ^a,b  

^a Sandoz Pharma Ltd   (Switzerland)

^b NONE   (Germany)

Author keywords

Animal models; Autoimmune disease; Pharmaceuticals; Systemic hypersensitivity

Indexed keywords

ALLYL COMPOUND; AMINO ACID; ANILIDE; ANTIINFECTIVE AGENT; ANTITHYROID AGENT; AROMATIC AMINE; CENTRAL NERVOUS SYSTEM AGENTS; DIBENZAZEPINE DERIVATIVE; GOLD DERIVATIVE; HALOTHANE; HYDANTOIN DERIVATIVE; HYDRAZINE DERIVATIVE; MERCURIC CHLORIDE; NITROFURANTOIN; OXAZOLIDINEDIONE DERIVATIVE; PENICILLAMINE; PENICILLIN DERIVATIVE; PENICILLIN G; PHENOTHIAZINE DERIVATIVE; PHENYTOIN; PROCAINAMIDE; PYRAZOLONE DERIVATIVE; SUCCINIMIDE DERIVATIVE; SULFONAMIDE; THIOUREA DERIVATIVE;

AUTOIMMUNITY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; ETIOLOGY; GLOMERULONEPHRITIS; HUMAN; IMMUNE DEFICIENCY; LYMPHOPROLIFERATIVE DISEASE; MACROMOLECULE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXIC OIL SYNDROME; TOXICOLOGY;

EID: 0030025285     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159603000135     Document Type: Review

References (25)

1. Adams LE, Hess EV. Drug-Related Lupus. Incidence, Mechanisms and Clinical Implications. Drug Saf. 1991;6:431-449.
2. Kammüller ME, Bloksma N, Seinen W, Autoimmunity and Toxicology. Immune Disregulation Induced by Drugs and Chemicals. In: Kammüller ME, Bloksma N, Seinen W, eds. Autoimmunity and Toxicology. Amsterdam: Elsevier Science Publishers; 1989:3-34.
3. Uetrecht JP. The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions. Drug Metab Rev. 1992;24:299-366.
4. Aldridge WN. The toxic oil syndrome (TOS, 1981): from the disease towards a toxicological understanding of its chemical aetiology and mechanism. Toxicol Lett. 1992;64/65:59-70.
5. Mayeno AN, Gleich GJ. Eosinophilia-myalgia syndrome and tryptophan production: a cautionary tale. Trends Biotech. 1994;12:346-352.
6. Rubin RL. Autoimmune reactions induced by procainamide and hydralazine. In: Kammüller ME, Bloksma N, Seinen W, eds. Autoimmunity and Toxicology. Amsterdam: Elsevier Science Publishers; 1989:119-150.
7. Krueger GRF. The pathology of diphenylhydantoin-induced lymphoproliferative reactions in animals. In: Kammüller ME, Bloksma N, Seinen W, eds. Autoimmunity and Toxicology. Amsterdam: Elsevier Science Publishers; 1989:391-413.
8. Gut J, Christen U, Frey N, Koch V, Stoffler D. Molecular mimicry in halothane hepatitis: biochemical and structural characterization of lipoylated autoantigens. Toxicology. 1995;97:199-224.
9. H2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today. 1991;12:223-227.
10. Sinigaglia F. The molecular basis of metal recognition by T cells. J Invest Dermatol. 1994;102:398-401.
11. Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science. 1994;266:810-813.
12. Shoenfeld Y, Isenberg D. The mosaic of autoimmunity. The factors associated with autoimmune disease. In: Research Monographs in Immunology Volume 12. Amsterdam: Elsevier Science Publishers; 1989.
13. Mason D. Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunol Today. 1991;12:57-60.
14. Martin S, Weltzien HU. T cell recognition of haptens, a molecular view. Int Arch Allergy Immunol. 1994;104:10-16.
15. Gleichmann E, Vohr H-W, Stringer C, Nuyens J, Gleichmann H. Testing the sensitization of T cells to chemicals. From murine graft-versus-host (GVH) reactions to chemical-induced GVH-like immunological diseases. In: Kammüller ME, Bloksma N, Seinen W. eds. Autoimmunity and Toxicology. Amsterdam: Elsevier Science Publishers; 1989:363-390.
16. Bloksma N, de Bakker JM, van Rooijen HJM, Punt P, Seinen W, Kammüller ME. Long-term treatment with 5,5-diphenylhydantoin reduces lymphadenopathy and anti-ssDNA autoantibodies in C57BL/6-lpr/lpr mice. Int J Immunopharmac. 1994;16:261-268.
17. Bell SA, Hobbs MV, Rubin RL. Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome. J Immunol. 1992;148:3369-3376.
18. Kimber I, Dearman RJ, Scholes EW, Basketter DA. The local lymph node assay: developments and applications. Toxicology. 1994;93:13-31.
19. Vial T, Descotes J. Contact sensitization assays in guinea pigs: are they predictive of the potential for systemic allergic reactions? Toxicology. 1994;93:63-75.
20. Osterland CK. Laboratory diagnosis and monitoring in chronic systemic autoimmune diseases. Clin Chem. 1994;40(11B):2146-2153.
21. Naparstek Y, Plotz PH. The role of autoantibodies in autoimmune disease. Ann Rev Immunol. 1993;11:79-104.
22. Kroemer G, Andreu JL, Gonzalo JA, Gutierrez-Ramos JC, Martinez-A C. Interleukin-2, auto-tolerance, and autoimmunity. Adv Immunol. 1991;50:147-235.
23. Troutt AB, Kelso A. Lymphokine synthesis in vivo in an acute murine graft-versus-host reaction: mRNA and protein measurements in vivo and in vitro reveal marked differences between actual and potential lymphokine production levels. Int Immunol. 1993;5:399-407.
24. Akira S, Taga T, Kishomoto T. Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1-78.
25. Kubicka-Muranyi M, Goebels R, Goebel C, Uetrecht J, Gleichmann E. T lymphocytes ignore procainamide, but respond to its reactive metabolites in peritoneal cells: demonstration by the adoptive transfer popliteal lymph node assay. Toxicol Appl Pharmacol. 1993;122:88-94.